MedTrace Logo

Effectiveness of the uPatient Platform in Prophylactic Treatment in Hemophilia

NCT02581735 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2016-06-30

No results posted yet for this study

Summary

Research project whose main objective is to evaluate the use of a technology platform (uPatient) to register the prophylactic treatment of patients with hemophilia treated in different Hematology and Hemotherapy services of several hospitals in Spain.

Conditions

  • Haemophilia

Interventions

OTHER

Patients with haemophilia

Using the platform Upatient, patients with hemophilia will register for one year, the prophylactic treatment who receive at home. Likewise, they indicate a replacement therapy as a result of joint bleeds. At baseline, a month, 6 months and at the end of the study, patients shall complete two questionnaires. The same way in the initial evaluation and end of the study, the clinical joint status will be evaluated with HJHS scale .

Sponsors & Collaborators

  • Universidad de Murcia

    collaborator OTHER

  • Medtep Inc.

    collaborator INDUSTRY

  • Real Fundación Victoria Eugenia

    lead OTHER

Principal Investigators

  • Rubén Cuesta-Barriuso, PhD · Real Fundación Victoria Eugenia

Eligibility

Min Age
13 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-11-30
Completion
2016-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02581735 on ClinicalTrials.gov